Endovascular Management of Lower Limb Claudication due to Infra-Inguinal Disease

  • Robert R. Attaran
  • Carlos I. Mena-Hurtado

Case Report

An 80-year-old man with known peripheral artery disease and prior left superficial femoral artery (SFA) endovascular interventions comes to see you in clinic complaining of left calf heaviness from walking 100 yards. Medical history includes coronary artery disease, hypertension, diabetes and obesity. He cannot recall details but states that his last intervention was approximately 3 years ago at another institution. He tells you that he has previously tried cilostazol but stopped taking it due to pedal edema and gastric upset.

On your physical examination both femoral pulses are palpable, the popliteal pulses are difficult to palpate due to habitus and the left pedal pulses are appreciable by hand-held Doppler only. You order a bilateral US Duplex arterial study. The study reports restenosis in the left SFA. As the patient is severely symptomatic you proceed with invasive angiography.

Question 1

Which of the following statements is NOT correct?

  1. A.

    The SFA stented segment is...


  1. 1.
    Krankenberg H, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Tepe G, et al. Drug-Coated Balloon versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and/or Popliteal Peripheral Artery Disease: 12-Month Results from the IN.PACT SFA Randomized Trial. Circulation. 2015;131(5):495–502.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Rosenfield K, for the LEVANT 2 Investigators, et al. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med. 2015;373:145–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Tepe G. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv. 2015;8(1 Pt A):102–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Tepe G, et al. High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther. 2013;20(6):792–800.CrossRefPubMedGoogle Scholar
  6. 6.
    Coronary Artery angiographic changes after PTCA: Manual of Operations NHBLI PTCA Registry 1985-6:9.Google Scholar
  7. 7.
    Adlakha S, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol. 2010;23:411–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Iida O, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol. 2006;98:272–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Scheinert D, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45(2):312–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Laird JR, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Davaine JM, et al. One-year clinical outcome after primary stenting for trans-atlantic inter-society consensus (TASC) C and D femoropopliteal lesions (the STELLA “stenting long de l’artere femorale superficielle” cohort). Eur J Vasc Endovasc Surg. 2012;44:432–41.CrossRefPubMedGoogle Scholar
  12. 12.
    Bosiers M, et al. Zilver PTX Single-Arm Study Investigators. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg. 2013;54(1):115–22.Google Scholar
  13. 13.
    Werner M, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Lin Y, et al. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency. J Endovasc Ther. 2015;22(3):319–26.CrossRefPubMedGoogle Scholar
  15. 15.
    Antoniou GA, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg. 2013;57(1):242–53.CrossRefPubMedGoogle Scholar
  16. 16.
    Pereira CE, et al. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg. 2006;44(3):510–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Section of Cardiovascular MedicineYale UniversityNew HavenUSA

Personalised recommendations